Free Trial

AstraZeneca (AZN) SEC Filings & 10K Form

AstraZeneca logo
$70.87 +0.49 (+0.70%)
Closing price 04:00 PM Eastern
Extended Trading
$70.72 -0.15 (-0.21%)
As of 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent AstraZeneca SEC Filings

DateFilerForm TypeView
05/27/2025
5:09 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2025
7:56 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2025
8:41 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2025
6:20 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/09/2025
10:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2025
8:53 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2025
8:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2025
8:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2025
12:07 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2025
10:44 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2025
11:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2025
11:22 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2025
6:55 PM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/22/2025
5:37 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
12:40 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2025
5:00 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Form SCHEDULE 13G/A
04/04/2025
5:43 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2025
5:06 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2025
11:30 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2025
6:16 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2025
6:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2025
7:32 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
6:17 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
6:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
6:30 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2025
2:33 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
9:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
6:17 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
6:20 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
5:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
10:06 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2025
9:52 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
9:22 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
5:00 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
8:29 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2025
5:08 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
5:59 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
9:30 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
7:02 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
6:49 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
8:53 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
02/05/2025
11:15 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form EFFECT
02/03/2025
12:05 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
5:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
8:25 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2025
8:52 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Cellectis S.A. (Subject)
Form SCHEDULE 13D/A
01/21/2025
11:17 AM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Form F-6
Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts  
01/21/2025
5:40 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2025
6:13 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2025
9:04 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
10:05 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
11:13 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/16/2024
9:04 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
8:01 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
9:28 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
9:35 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
5:43 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
5:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
8:13 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
5:48 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
11:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2024
6:10 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
8:10 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
10:46 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
5:00 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Monopar Therapeutics (Subject)
Form SC 13G
10/21/2024
8:48 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
5:01 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Form SC 13G
10/07/2024
5:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
9:45 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
5:42 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
5:44 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
5:27 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
12:34 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
9:50 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
5:05 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
9:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
5:26 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2024
5:00 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/26/2024
5:42 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
8:06 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
5:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
9:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
5:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2024
4:00 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
5:12 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
5:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
5:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
White House to reset Social Security? (Ad)

Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.

And it could have a major impact on how you collect Social Security - Click here to understand what'
06/17/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2024
9:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
9:02 AM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
06/03/2024
9:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
9:29 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
5:35 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AZN) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners